Pholcodine Cough Medicines Pulled Over Safety Fears
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced it is removing pholcodine-based cough and cold medicines from the market. A thorough safety review found the risks outweigh the benefits.
Rare But Serious Allergy Risk Linked to Pholcodine
Pholcodine, a common cough suppressant, has been linked to a rare but severe allergic reaction called anaphylaxis. This reaction affects patients during general anaesthesia when muscle relaxants are used. A recent 2022 study reinforced this dangerous connection, although the overall risk remains very small.
MHRA Issues Precautionary Warning
Dr Alison Cave, MHRA’s Chief Safety Officer, emphasised safety as the top priority:
“Following a thorough scientific review and advice from the independent Commission on Human Medicines, we recommend these products should no longer be used as a precaution.”
“If your cough medicine contains pholcodine, check the packaging carefully. Speak to your pharmacist for alternative remedies.”
“If you have surgery planned, tell your anaesthetist if you’ve used pholcodine in the last year. Anaesthetists are trained to manage these rare allergic reactions.”
For more information or advice, patients are urged to consult their pharmacist immediately.
